SCHEMBL23529643

SCHEMBL23529643

COC(=O)c1ccc(Cn2cccn2)cc1[N+](=O)[O-]

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.47
TSHR P16473 1/20 0.47
KMT2A Q03164 1/20 0.47
HTT P42858 4/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
ALDH1A1 P00352 2/20 0.42
ALOX15 P16050 1/20 0.42
HSD17B10 Q99714 1/20 0.42
MAPT P10636 3/20 0.42
USP2 O75604 1/20 0.42
GAA P10253 1/20 0.42
KLKB1 P03952 1/20 0.41
TDP1 Q9NUW8 1/20 0.40
KAT7 O95251 1/20 0.40
KAT6A Q92794 1/20 0.40
NOS3 P29474 1/20 0.39
NOS1 P29475 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28837235 0.86 HTT (0.55) MEN1TSHRKMT2AHTTHDAC1
SCHEMBL31172538 0.81 HTT (0.52) MEN1TSHRKMT2AHTTHDAC1
SCHEMBL13634220 0.80 ALDH1A1 (0.48) MEN1TSHRKMT2AHTTALDH1A1
SCHEMBL23631796 0.79 HTT (0.54) MEN1TSHRKMT2AHTTHDAC1
SCHEMBL23529840 0.77 HTT (0.47) MEN1TSHRKMT2AHTTHDAC1
SCHEMBL5906474 0.77 HTT (0.46) MEN1TSHRKMT2AHTTHDAC1
SCHEMBL23529842 0.76 MEN1 (0.44) MEN1TSHRKMT2AHTTHDAC1
SCHEMBL1887396 0.76 L3MBTL1 (0.52) KMT2AALDH1A1MAPTTDP1
SCHEMBL590781 0.76 TTR (0.47) MEN1TSHRKMT2AALDH1A1ALOX15
SCHEMBL28591404 0.76 CA12 (0.43) MEN1TSHRKMT2AHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113004286-B Tricyclic compounds as plasma kallikrein inhibitors and uses thereof 成都康弘药业集团股份有限公司 2022-08-12 CN disclosed
WO-2021121396-A1 TRICYCLIC COMPOUND THAT ACTS AS PLASMA KALLIKREIN INHIBITOR AND USE THEREOF 成都康弘药业集团股份有限公司 2021-06-24 WO disclosed
CN-113004286-A Tricyclic compounds as plasma kallikrein inhibitors and uses thereof 成都康弘药业集团股份有限公司 2021-06-22 CN disclosed